HUTCHMED begins HMPL-A83 phase 1 trial in advanced malignant neoplasms
HUTCHMED (China) has launched a phase 1 clinical trial of its oncology drug candidate HMPL-A83 in China in patients having advanced malignant neoplasms. HMPL-A83 is ... Read More
Italy’s Menarini to acquire US biopharma company Stemline Therapeutics
Menarini acquisition of Stemline : Menarini Group, an Italian pharma and diagnostics company, has agreed to acquire US biopharma company Stemline Therapeutics in a deal ... Read More
Differences between Malignant Tumors and Benign Tumors
What are the Characteristics of Neoplasia? Neoplasia comprises of both malignant and benign tumors. What are the differences between Malignant Tumors and Benign Tumors? Benign ... Read More